Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures, and Tiger Global
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series […]
Anomaly Raises $17 Million to Scale Precision Payments Platform Across Healthcare Industry
Anomaly, a precision payments platform using artificial intelligence (AI) to improve payment accuracy in the […]
Freenome Shows Continued Leadership in Colorectal Cancer Research
Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology […]
Heidelberg Ion Beam Therapy Center Treats First Patient Using Helium Ion Therapy with RayStation
Heidelberg Ion Beam Therapy Center (HIT) has treated its first patient using helium ion therapy […]
Exciva Raises €9 Million in Series A Round Led by Andera Partners
Exciva GmbH, a clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in […]
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has received funding […]
Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients […]
Roche Launches Comprehensive Genomic Profiling Kit to Expand Access to Personalised Cancer Research
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has launched the AVENIO Tumor Tissue […]
Former Vaccine Chief Returns As NHS Prepares For Winter
NHS chief executive Amanda Pritchard today announced that former vaccine chief Dr Emily Lawson is returning […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more